Background: The JPLT3‐S (Japanese Study Group for Pediatric Liver Tumors‐3) study, conducted cisplatin (CDDP) monotherapy for young children (<3 years old) with standard‐risk hepatoblastoma (HB) using a central review system in Japan. In the previous JPLT2 study, cases with resectable tumors without any annotation factors in the PRETEXT (PRETreatment EXTent of disease) classification (standard‐risk HB) showed favorable outcomes with treatment consisting of CDDP and pirarubicin, but showed toxicities and late complications. In the JPLT3‐S trial, a less intense regimen consisting of CDDP alone was evaluated.Methods: Patients who were less than 3 years of age and with PRETEXT I, II, or III HB without any annotation factors (e.g., E1, E1a, E2, E2a, H1, N1, P2, P2a, V3, and V3a) were eligible for inclusion in this study. In this trial, the central radiological and pathological features of all patients were reviewed. The primary outcome was the 3‐year progression‐free survival (PFS).Results: A total of 38 patients (23 female) were included. The median patient age was 12 months (range: 2–34). Two patients discontinued treatment because of progressive disease, and five patients discontinued treatment for other reasons. The 3‐year PFS rate was 93.9% (95% confidence interval [CI]: 86.4%–100%). All 38 patients survived (follow‐up period 38–98 months), and the OS rate was 100% (CI: 100). Eighteen of the 38 patients (47.4%) experienced ototoxicity as a late complication.Conclusion: CDDP monotherapy regimen is feasible in young patients with localized HB, as classified by a central review.
Purpose: We developed an interventional radiology (IR) simulator using a virtual reality system (the VR–IR simulator) to teach IR procedures to medical students. In this study, we investigated the effectiveness of this teaching method. Materials and methods: All ninety-nine fifth-year medical students attended a conventional classroom lecture. To teach students the actual procedure, they were randomly divided into two groups: One received conventional verbal explanations and educator demonstrations (the conventional group [n = 44]), and the other received VR–IR simulator training (the VR–IR simulator group [n = 55]). Afterward, they underwent a test using an augmented reality- (AR-) IR simulator (the VIST® G5 image-guided AR–IR simulator, Mentice, Gothenburg, Sweden). The total procedure time, amount of contrast media used, fluoroscopic time, and patient peak skin dose in the simulated patients were compared between groups. A board-certified radiologist evaluated ten aspects of the procedure technique using a 5-point Likert scale (total: 50 points). Results: Two students in the VR–IR simulator group were excluded due to VR sickness and simulator malfunction. There were no significant differences between the VR–IR simulator group and the conventional group regarding total procedure time (median [25–75% interquartile range]: 13.5 [11.8–14.5] vs. 14.3 [12.3–16.8] minutes, p = 0.11), fluoroscopic time (10.1 [8.5–13.0] vs. 11.0 [8.6–13.7] minutes, p = 0.31), and patient peak skin dose (276 [243–373] vs. 303 [239–395] mGy, p = 0.57), respectively. However, the amount of contrast media used was significantly lower (28.0 [21.0–36.2] vs. 40.0 [32.3–50.9] mL, p < 0.01) and the technical achievement scores by the radiologist (36 [34–44] vs. 31 [29–32], p < 0.01) were significantly higher in the VR–IR simulator group. Conclusion: The VR–IR simulator helped reduce the amount of contrast media in interventional procedures and improved technical achievement scores.
In the JPLT3 study, a real-time central surgical reviewing (CSR) system was employed aimed at facilitating early referral of candidates for liver transplantation (LTx) to centers with pediatric LTx services. The expected consequence was surgery, including LTx, conducted at the appropriate time in all cases. This study aimed to review the effect of CSR on institutional surgical decisions in cases enrolled in the JPLT3 study. Real-time CSR was performed in cases in which complex surgeries were expected, using images obtained after two courses of preoperative chemotherapy. Using the cloud-based remote image viewing system, an expert panel consisting of pediatric and transplant surgeons reviewed the images and commented on the expected surgical strategy or the necessity of transferring the patient to a transplant unit. The results were summarized and reported to the treating institutions. A total of 41 reviews were conducted for 35 patients, and 16 cases were evaluated as possible candidates for LTx, with the treating institutions being advised to consult a transplant center. Most of the reviewed cases promptly underwent definitive liver surgeries, including LTx per protocol.
Objective: Short bowel syndrome (SBS) is a severe intestinal disease that causes malabsorption. Long-term parental nutrition therapy induces infection and liver failure. For the surgical management of intestinal rehabilitation, the intestinal loop lengthening method and serial transverse enteroplasty (STEP) method have been reported, although their effects have proven limited. We herein report a new surgical technique, Saeki–Spiral–Shark (3S) method for SBS using biomimetics of shark intestine. Methods: In the 3S method, a spiral valve is formed inside the intestine by external sutures. Using a 25 cm length intestinal organ model, we performed both the 3S method and STEP procedure. We then compared the length and fluid passage times of the subsequently formed intestine. Results: After the 3S method was performed, the length of the intestinal model changed to 22 cm, and after the STEP procedure, that was elongated to 30 cm. Although the water passage times did not change markedly, the semi-digestive nutritional supplement passage time slowed down in the model with the 3S method. There was slight leakage in the STEP procedure model. Conclusions: The 3S method is a unique method of treating SBS based on biomimetics. This procedure does not require an incision of the intestine, which thereby enabling clean and less-invasive surgery. We plan to conduct animal experiments in the future.
Purpose: The purpose of this report was to evaluate the safety and efficacy of the simple laparoscopic percutaneous extraperitoneal closure (LPEC) method for treating ovarian hernia patients, including newborns and low-birth-weight infants. Methods: We retrospectively reviewed the cases of ovarian hernia that were treated in our institution from May 2012 to September 2017. Results: Thirty-four infants were included in this study (right side, n = 8; left side, n = 22; bilateral, n = 4). The mean corrected age was 2.3 ± 2.8 months and the mean body weight was 4.4 ± 1.6 kg. The contralateral positive rate was 53%, and 34% of the cases showed sliding of the fallopian tube. Umbilical hernias were observed in 24 cases (71%). The mean operative time was 53 ± 20 minutes. The LPEC procedure was successful in 32 cases; two cases were converted to open surgery. Conclusion: Small infants with ovarian hernia have some specific features such as a shortened round ligament and the presence of peritoneum cavities that require skillful techniques when being surgically repaired. The simple LPEC procedure can be performed safely with a low risk of recurrence, even in infants with sliding of the fallopian tube.